217 related articles for article (PubMed ID: 20525687)
21. Comparative analysis of type III effector translocation by Yersinia pseudotuberculosis expressing native LcrV or PcrV from Pseudomonas aeruginosa.
Bröms JE; Sundin C; Francis MS; Forsberg A
J Infect Dis; 2003 Jul; 188(2):239-49. PubMed ID: 12854079
[TBL] [Abstract][Full Text] [Related]
22. Proinflammatory signalling stimulated by the type III translocation factor YopB is counteracted by multiple effectors in epithelial cells infected with Yersinia pseudotuberculosis.
Viboud GI; So SS; Ryndak MB; Bliska JB
Mol Microbiol; 2003 Mar; 47(5):1305-15. PubMed ID: 12603736
[TBL] [Abstract][Full Text] [Related]
23. Calcium-responsive plasmid copy number regulation is dependent on discrete YopD domains in Yersinia pseudotuberculosis.
Engling P; Héchard T; Edgren T; Francis M; Dersch P; Wang H
Plasmid; 2023 May; 126():102683. PubMed ID: 37075853
[TBL] [Abstract][Full Text] [Related]
24. LcrV is a channel size-determining component of the Yop effector translocon of Yersinia.
Holmström A; Olsson J; Cherepanov P; Maier E; Nordfelth R; Pettersson J; Benz R; Wolf-Watz H; Forsberg A
Mol Microbiol; 2001 Feb; 39(3):620-32. PubMed ID: 11169103
[TBL] [Abstract][Full Text] [Related]
25. Role of SycD, the chaperone of the Yersinia Yop translocators YopB and YopD.
Neyt C; Cornelis GR
Mol Microbiol; 1999 Jan; 31(1):143-56. PubMed ID: 9987117
[TBL] [Abstract][Full Text] [Related]
26. Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis.
Frithz-Lindsten E; Holmström A; Jacobsson L; Soltani M; Olsson J; Rosqvist R; Forsberg A
Mol Microbiol; 1998 Sep; 29(5):1155-65. PubMed ID: 9767584
[TBL] [Abstract][Full Text] [Related]
27. Impact of host membrane pore formation by the Yersinia pseudotuberculosis type III secretion system on the macrophage innate immune response.
Kwuan L; Adams W; Auerbuch V
Infect Immun; 2013 Mar; 81(3):905-14. PubMed ID: 23297383
[TBL] [Abstract][Full Text] [Related]
28. YopD of Yersinia pestis plays a role in negative regulation of the low-calcium response in addition to its role in translocation of Yops.
Williams AW; Straley SC
J Bacteriol; 1998 Jan; 180(2):350-8. PubMed ID: 9440524
[TBL] [Abstract][Full Text] [Related]
29. YopB and YopD constitute a novel class of Yersinia Yop proteins.
Håkansson S; Bergman T; Vanooteghem JC; Cornelis G; Wolf-Watz H
Infect Immun; 1993 Jan; 61(1):71-80. PubMed ID: 8418066
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of the Yersinia enterocolitica type III secretion chaperone SycD in complex with a peptide of the minor translocator YopD.
Schreiner M; Niemann HH
BMC Struct Biol; 2012 Jun; 12():13. PubMed ID: 22708907
[TBL] [Abstract][Full Text] [Related]
31. Bimolecular fluorescence complementation assay to explore protein-protein interactions of the Yersinia virulence factor YopM.
Uğurlu Ö; Evran S
Biochem Biophys Res Commun; 2021 Dec; 582():43-48. PubMed ID: 34689104
[TBL] [Abstract][Full Text] [Related]
32. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation.
Pettersson J; Holmström A; Hill J; Leary S; Frithz-Lindsten E; von Euler-Matell A; Carlsson E; Titball R; Forsberg A; Wolf-Watz H
Mol Microbiol; 1999 Jun; 32(5):961-76. PubMed ID: 10361299
[TBL] [Abstract][Full Text] [Related]
33. YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane.
Holmström A; Petterson J; Rosqvist R; Håkansson S; Tafazoli F; Fällman M; Magnusson KE; Wolf-Watz H; Forsberg A
Mol Microbiol; 1997 Apr; 24(1):73-91. PubMed ID: 9140967
[TBL] [Abstract][Full Text] [Related]
34. Regulation of Yersinia Yop-effector delivery by translocated YopE.
Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
[TBL] [Abstract][Full Text] [Related]
35. Genetically engineered frameshifted YopN-TyeA chimeras influence type III secretion system function in Yersinia pseudotuberculosis.
Amer AA; Costa TR; Farag SI; Avican U; Forsberg Å; Francis MS
PLoS One; 2013; 8(10):e77767. PubMed ID: 24098594
[TBL] [Abstract][Full Text] [Related]
36. Conformational analysis by CD and NMR spectroscopy of a peptide encompassing the amphipathic domain of YopD from Yersinia.
Tengel T; Sethson I; Francis MS
Eur J Biochem; 2002 Aug; 269(15):3659-68. PubMed ID: 12153562
[TBL] [Abstract][Full Text] [Related]
37. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.
Zwack EE; Snyder AG; Wynosky-Dolfi MA; Ruthel G; Philip NH; Marketon MM; Francis MS; Bliska JB; Brodsky IE
mBio; 2015 Feb; 6(1):e02095-14. PubMed ID: 25691590
[TBL] [Abstract][Full Text] [Related]
38. Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.
Zwack EE; Feeley EM; Burton AR; Hu B; Yamamoto M; Kanneganti TD; Bliska JB; Coers J; Brodsky IE
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784930
[TBL] [Abstract][Full Text] [Related]
39. YopN and TyeA Hydrophobic Contacts Required for Regulating Ysc-Yop Type III Secretion Activity by Yersinia pseudotuberculosis.
Amer AA; Gurung JM; Costa TR; Ruuth K; Zavialov AV; Forsberg Å; Francis MS
Front Cell Infect Microbiol; 2016; 6():66. PubMed ID: 27446813
[TBL] [Abstract][Full Text] [Related]
40. Interaction of the Yersinia pestis type III regulatory proteins LcrG and LcrV occurs at a hydrophobic interface.
Matson JS; Nilles ML
BMC Microbiol; 2002 Jun; 2():16. PubMed ID: 12102728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
